Latest News from NPR

on:

NCPR is supported by:

 
Hourly Newscast
4 min., 45 sec.

Programs

Latest program rundown

Coming up:

Latest Features:
Tommy Trenchard for NPR
August 28, 2014 | NPR · For the first time, researchers have tracked the spread of Ebola, almost in real time, during an outbreak. The virus is quickly changing its genetic code. But it's unclear what the mutations mean.
 
August 29, 2014 | NPR · French President Francois Hollande is under pressure to fix the country's economy, which is overburdened by regulation and failing a generation of young people. He's also facing calls for austerity.
 
Getty Images
August 29, 2014 | NPR · Congressman and former Republican vice presidential nominee Paul Ryan discusses his new book, The Way Forward: Renewing the American Idea.
 

Latest program rundown

Coming up:

Latest Features:
AP
August 29, 2014 | NPR · The Obama administration is considering whether to broaden its air campaign against the extremist group the Islamic State by striking targets in Syria.
 
August 29, 2014 | NPR · Regular political commentators, E.J. Dionne of The Washington Post and David Brooks of The New York Times, discuss the latest in Ukraine and the actions of ISIS in Iraq and Syria.
 
Getty Images
August 29, 2014 | NPR · An earthquake in Napa Valley this week brought back old fears for author Gustavo Arellano. In his anxiety he's revisiting the book A Crack in the Edge of the World.
 

Latest Saturday rundown




WE Saturday Feature

August 30, 2014 | NPR · Latest news from Novoazovsk, Ukraine, where Ukrainian forces are defending the port city from what they say is a Russian invasion. NPR's Scott Simon talks to correspondent Soraya Sarhaddi Nelson from Novoazovsk.
 

Latest Sunday rundown


WE Sunday Feature

August 24, 2014 | NPR · In the wake of violent clashes between protesters and police in Ferguson, Mo., President Obama is ordering a review of the federal programs that help local police departments purchase military gear.
 

Latest program rundown

Coming up:

Pharmaceuticals

Aug 29, 2014 — Even when monkeys were near death, an Ebola treatment called ZMapp was able to save them. The drug has been used in a few people, but the limited supply has been exhausted.
Launch in player | Comments |
Aug 21, 2014 — Even though the current outbreak in West Africa has become the largest ever, Ebola isn't the most attractive business proposition for drugmakers. The right financial incentives might change that.
Comments |
Aug 8, 2014 — No doctor would refuse to prescribe cholesterol-lowering statins to patients because they're overweight. But despite guidelines, some doctors aren't offering preventive drugs to those at risk for HIV.
Launch in player | Comments |
Jul 25, 2014 — A husband and wife who are doctors have been working on fact boxes for drugs that, like nutrition labels for foods, would more concisely convey a medicine's benefits and risks.
Launch in player | Comments |
Jul 11, 2014 — There's overmedicating and self-medicating, but some vets are "de-medicating." Prescribed multiple drugs to deal with PTSD and pain, they've stopped taking them — without authorization.
Launch in player | Comments |
Jun 23, 2014 — Drugmakers offer medicines at a bargain price to hospitals that treat large numbers of poor patients. Hospitals sometimes resell the drugs at full price and make hefty profits.
Launch in player | Comments |
May 20, 2014 — Medicare gives itself the power to ban doctors if they prescribe medications in abusive ways. The action follows a ProPublica series that found inappropriate prescribing, waste and fraud.
Comments |
May 16, 2014 — The Food and Drug Administration's approval of a new drug for leishmaniasis came with a voucher that can be redeemed to speed up the approval of a much more lucrative drug in the future.
Comments |
May 12, 2014 — Once a drug is approved by the FDA, doctors can use it as they see fit. That can be brilliant or risky, depending on the medication and the patient.
Launch in player | Comments |
May 6, 2014 — German drug company Bayer makes a deal with U.S.-based Merck & Co. The purchase includes brands such as Claritin, Coppertone and Dr. Scholl's.
Comments |
more Pharmaceuticals from NPR